Queensland immunisation schedule
Additional immunisation programs:
- Annual influenza program
- National Shingles Vaccination Program
- No Jab, No Pay
- Whooping cough vaccination for pregnant women
- Meningococcal ACWY Vaccination Program
November 2016 Queensland immunisation schedule
These routine immunisations are recommended and funded for Queensland children and adults. Refer to the Australian Immunisation Handbook for the latest information.
Different brands of the same vaccines will be used in the schedule.
Additional vaccines are funded for:
A printable poster of the National Immunisation Program Schedule Queensland (PDF, 2.24MB) is available for clinicians to download.
|Birth||Hepatitis B||HBVaxII (paediatric)TM|
2, 4 & 6 months
4 & 6 month vaccinations should be given at 4 & 6 months
PriorixTM or M-M-R IITM
Priorix TetraTM or ProQuadTM
InfanrixTM or TripacelTM
|Adults (over 65 years)|
|Adults 70 years||Herpes zoster||Zostavax|
|12 months||Pneumococcal disease||*Prevenar 13TM|
|4 years||Pneumococcal disease||*Pneumovax 23TM|
*Refer to Conditions associated with an increased risk of invasive pneumococcal disease (IPD) in current Australian Immunisation Handbook.
#All Aboriginal and Torres Strait Islander children aged 6 months to less than 5 years of age are eligible to receive influenza vaccine annually.
|From 6 months to less than 5 years of age|
|Refer to Annual Influenze Program below|
|12 months||Hepatitis A||Vaqta PaediatricTM|
|Adults (15 to 65 years)|
Hepatitis B vaccination is funded for:
- low-birth weight preterm newborn infants (<2000g) and/or infants born at <32 weeks gestation (irrespective of weight), who should receive a booster of a hepatitis B-containing vaccine at 12 months of age
- household or other close (household-like) contacts of people with hepatitis B
- sexual contacts of people with hepatitis B
- migrants (who have a Medicare card) from hepatitis B endemic countries (if non-immune/not previously vaccinated)
- Aboriginal and Torres Strait Islander people (if non-immune/not previously vaccinated)
- people with chronic liver disease and/or hepatitis C
- people who inject drugs.
Hepatitis B vaccine is recommended (but not funded) for other individuals who may be at risk of hepatitis B. Refer to the Australian Immunisation Handbook for further details.
Measles, mumps, rubella (MMR) vaccine
Two doses of MMR containing vaccine are recommended for all children. The first dose should be given at 12 months of age as MMR vaccine. The second dose should be given at 18 months of age as MMRV vaccine.
Do not give MMRV vaccine as the first dose of MMR containing vaccine in children less than 4 years of age.
People born during or since 1966 who have not already received 2 doses of a measles-containing vaccine should also be vaccinated.
Annual influenza program
Queensland Health coordinates the National Influenza Immunisation Program for eligible groups across the state.
National Shingles Vaccination Program
The National Shingles Vaccination Program commences in November 2016 for adults 70 years of age, with a single catch-up dose funded for adults aged 71 to 79 years until 2021.
No Jab, No Pay
Free catch-up vaccines are provided only for people under 20 years of age whose families are currently receiving family assistance payments. This program will finish in December 2017.
HPV vaccinations are not included in this program.
Whooping cough vaccination for pregnant women
Vaccination is recommended with each pregnancy to provide maximum protection for newborn babies. This includes pregnancies which are close together (e.g. less than 2 years).
The Australian Immunisation Handbook recommends vaccination of pregnant women early in the third trimester (between 28 and 32 weeks), but it can be given any time during the last 3 months of pregnancy.
Meningococcal ACWY Vaccination Program
The Queensland Government is offering free meningococcal ACWY vaccination to all:
- Year 10 students through the School Immunisation Program from term 2, 2017
- people aged between 15 to 19 years through their doctor or immunisation provider from June 2017 until May 2018.